Some sharp eyed MDs have noticed something very disconcerting about the NIAID clinical trial on remdesivir. They still have not published the paper but MDs have noticed something very strange.
They changed the endpoints for the study in mid April, while it was still going on. The endpoints are the various results they use to judge the drug's efficacy or not on a given parameter. Changing these during a trial is a big no no, and it's got lots of Doctors doubting the science.
It's like being in a race and suddenly declaring victory where you are instead of continuing on the finish line. Very disappointing, someone needs to ask Dr Fauci some very pointed questions.
|